Content Rules, Inc.

A Lesson in Content Management: Vigilante Content is Always Well Intentioned

Vigilante content is all the content created (and often distributed) by people who are not tasked with creating content. It’s the content that someone thinks up and then writes. And then publishes or emails or prints to hand out at a conference. In essence, it is unauthorized content.
content strategy for pharma: stop using redundant content and focus on research | content rules | woman in scrubs at a board

Content Strategy for Pharma: Spend Time on Research, not on Redundant Content

We can no longer afford the costs of traditional, document-based content management in the pharmaceutical industry. We need pharma companies to prioritize content reuse and automation rather than manual, error-prone legacy processes.

I Personally Experienced a Personalized Experience at Scale – And I Liked It

In January 2022, I received my Year in Review video from WW (formerly Weight Watchers). The video showed me some fun stats about my participation in the program in 2021.

Solving Pharma Content Challenges

In The Unique Challenges of Pharma Content, we discuss challenges faced by pharmaceutical companies in the creation and management of content.

Manage the Information, Not (Just) the Document

For centuries, humans have shared information through documents. We’ve used digital files, printed paper, illuminated manuscripts, parchment scrolls, and clay tablets. Regardless of form factor, a document has traditionally been created as a single monolithic entity, authored in the same format in which it was intended to be consumed.

To Chunk or Not to Chunk? 3 Questions to Help You Decide

A question came up recently in a conversation about structured authoring and a migration into a component content management system: “If we’re not going to reuse this content, and it is always entirely unique, do we still need to chunk it into components?”